What is CVE-2024-53821?

CVE-2024-53821 is a high-severity vulnerability in Genetech Pie Register Premium, classified under Cross-site Scripting. CVSS score: 7.1/10. Published 2024-12-06.

How severe is CVE-2024-53821?

High severity. CVSS v3 base score is 7.1 out of 10.

Is CVE-2024-53821 known to be exploited?

2 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

XSS in Genetech Pie Register Premium

CVE-2024-53821

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Genetech Pie Register Premium allows Reflected XSS.This issue affects Pie Register Premium: from n/a before 3.8.3.3.

Vulnerability class: XSS (Cross-Site Scripting)

EPSS: 0.003 (18.5th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.1 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L.

Affected products

Genetech Pie Register Premium — versions n/a

Weakness classification (CWE)

CWE-79 — Cross-site Scripting

Public proof-of-concept exploits

References

audit@patchstack.com (vdb-entry)

Frequently asked questions

What is CVE-2024-53821?: CVE-2024-53821 is a high-severity vulnerability in Genetech Pie Register Premium, classified under Cross-site Scripting. CVSS score: 7.1/10. Published 2024-12-06.
How severe is CVE-2024-53821?: High severity. CVSS v3 base score is 7.1 out of 10.
Is CVE-2024-53821 known to be exploited?: 2 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.